Sunitinib induces apoptosis in pheochromocytoma tumor cells by inhibiting VEGFR2/Akt/mTOR/S6K1 pathways through modulation of Bcl-2 and BAD
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sunitinib induces apoptosis in pheochromocytoma tumor cells by inhibiting VEGFR2/Akt/mTOR/S6K1 pathways through modulation of Bcl-2 and BAD
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
Volume 302, Issue 6, Pages E615-E625
Publisher
American Physiological Society
Online
2011-08-31
DOI
10.1152/ajpendo.00035.2011
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting TOR dependence in cancer
- (2015) Oncotarget
- Differential Expression of S6K2 Dictates Tissue-Specific Requirement for S6K1 in Mediating Aberrant mTORC1 Signaling and Tumorigenesis
- (2011) C. Nardella et al. CANCER RESEARCH
- Targeting mTOR globally in cancer: Thinking beyond rapamycin
- (2011) Boris Shor et al. CELL CYCLE
- Dynamics of the Degradation of Ubiquitinated Proteins by Proteasomes and Autophagy
- (2011) Natura Myeku et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Sunitinib Acts Primarily on Tumor Endothelium rather than Tumor Cells to Inhibit the Growth of Renal Cell Carcinoma
- (2010) D. Huang et al. CANCER RESEARCH
- Sunitinib Induces Apoptosis and Growth Arrest of Medulloblastoma Tumor Cells by Inhibiting STAT3 and AKT Signaling Pathways
- (2010) F. Yang et al. MOLECULAR CANCER RESEARCH
- The BCL-2 Family Reunion
- (2010) Jerry E. Chipuk et al. MOLECULAR CELL
- Research Resource: Transcriptional Profiling Reveals Different Pseudohypoxic Signatures in SDHB and VHL-Related Pheochromocytomas
- (2010) Elena López-Jiménez et al. MOLECULAR ENDOCRINOLOGY
- Germline mutations in TMEM127 confer susceptibility to pheochromocytoma
- (2010) Yuejuan Qin et al. NATURE GENETICS
- Rapamycin inhibits mTORC1, but not completely
- (2009) Carson C. Thoreen et al. Autophagy
- Novel and Evolving Therapies in the Treatment of Malignant Phaeochromocytoma: Experience with the mTOR Inhibitor Everolimus (RAD001)
- (2009) M. R. Druce et al. HORMONE AND METABOLIC RESEARCH
- mTOR/S6 Kinase Pathway Contributes to Astrocyte Survival during Ischemia
- (2009) María Dolores Pastor et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Effect of Urotensin II on PC12 Rat Pheochromocytoma Cells
- (2009) Y. Aita et al. JOURNAL OF NEUROENDOCRINOLOGY
- Coordination of PGC-1β and iron uptake in mitochondrial biogenesis and osteoclast activation
- (2009) Kiyo-aki Ishii et al. NATURE MEDICINE
- The kinesin KIF1B acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor
- (2008) S. Schlisio et al. GENES & DEVELOPMENT
- Rationale and Evidence for Sunitinib in the Treatment of Malignant Paraganglioma/Pheochromocytoma
- (2008) Anthony M. Joshua et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Use of the Tyrosine Kinase Inhibitor Sunitinib in a Patient with von Hippel-Lindau Disease: Targeting Angiogenic Factors in Pheochromocytoma and Other von Hippel-Lindau Disease-Related Tumors
- (2008) Camilo Jimenez et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Patient With Malignant Paraganglioma Responding to the Multikinase Inhibitor Sunitinib Malate
- (2008) Noah M. Hahn et al. JOURNAL OF CLINICAL ONCOLOGY
- ConditionalPtenknock-out mice: a model for metastatic phaeochromocytoma
- (2008) Esther Korpershoek et al. JOURNAL OF PATHOLOGY
- Octreotide and the mTOR Inhibitor RAD001 (Everolimus) Block Proliferation and Interact with the Akt-mTOR-p70S6K Pathway in a Neuro-Endocrine Tumour Cell Line
- (2007) Simona Grozinsky-Glasberg et al. NEUROENDOCRINOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started